Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
PAION
PAION
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Byfavo
Remimazolam
2021-03-26
2027-2033
Conscious sedation
Xerava
Eravacycline
2018-09-20
2029-2037
Infections
,
Bacterial infections
,
Intraabdominal infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Remimazolam
biological availability
,
healthy volunteers/patients
,
substance-related disorders
,
general anesthesia
,
endoscopy
,
covid-19
,
sepsis
,
stroke
,
respiratory insufficiency
,
shock
,
wounds and injuries
,
anesthesia
,
colonoscopy
,
intravenous anesthesia
,
bronchoscopy
Benzodiazepine
anesthesia
Benzocaine
colonoscopy
Antithrombin iii
anesthesia
Desmoteplase
ischemic stroke
,
stroke
Sodium chloride
substance-related disorders
ENECADIN
ischemic stroke
,
stroke
Bolus
ischemic stroke
,
stroke
,
anesthesia
,
postoperative pain
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use